Peter Openshaw

Has grant

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Human Infection Challenge Network (HIC-Vac)

Open Date: 2022-05-23

Close Date: 2023-05-22

Grant: Close

Human Infection Challenge Vaccine (HIC-Vac) network

Open Date: 2017-01-01

Close Date:

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (10)

Ahilanandan Dushianthan

UNITED KINGDOM

View details

James Farrell

University of Edinburgh

UNITED KINGDOM

View details

Paul Morgan

Professor of Immunology

Cardiff University

UNITED KINGDOM

View details

Jerry Krishnan

University of Illinois Chicago (UIC)

UNITED STATES

View details

Matthew Siggins

Imperial College London

UNITED KINGDOM

View details

Stefan J. Marciniak

University of Cambridge

UNITED KINGDOM

View details

Ryan Thwaites

Lecturer in Respiratory Immunology

Imperial College London

UNITED KINGDOM

View details

Leah Cuthbertson

Lecturer

University of Leicester

UNITED KINGDOM

View details

Carlo Palmieri

University of Liverpool

UNITED KINGDOM

View details

John Kenneth Baillie

University of Edinburgh Roslin Institute

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Openshaw

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (15)

Using the 2024 National Academies of Science, Engineering, and Medicine Definition of Long COVID: Implications for Pulmonary and Critical Care Medicine

Antibody-mediated protection against respiratory syncytial virus in children

Human challenge models for vaccine development—strengths, limitations, and expansion into endemic settings: a HIC-Vac meeting report

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium

Long COVID: clues about causes

Single‐cell immune profiling reveals markers of emergency myelopoiesis that distinguish severe from mild respiratory syncytial virus disease in infants

Reply to Standaert, B. Comment on “Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium”

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.

Mucosal Immune Responses to Respiratory Syncytial Virus

Resilience of the respiratory microbiome in controlled adult RSV challenge study

COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol

Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses

A New Role for CXCL4 in Respiratory Syncytial Virus Disease

Seasonal and pandemic influenza: 100 years of progress, still much to learn

Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration

Collaborators (10)

Ahilanandan Dushianthan

James Farrell

Paul Morgan

Jerry Krishnan

Matthew Siggins

Stefan J. Marciniak

Ryan Thwaites

Leah Cuthbertson

Carlo Palmieri

John Kenneth Baillie

Make your next move.